Bunch Kathryn, Roberts Nia, Knight Marian, Nair Manisha
National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Bodleian Health Care Libraries, University of Oxford, Knowledge Centre, Oxford, UK.
BMJ Open. 2018 Dec 19;8(12):e021793. doi: 10.1136/bmjopen-2018-021793.
To conduct a systematic review to investigate the safety of induction and/or augmentation of labour compared with spontaneous-onset normal labour among pregnant women with iron-deficiency anaemia.
Systematic review.
Studies from all countries, worldwide.
Pregnant women with iron-deficiency anaemia at labour and delivery.
Any intervention related to induction and/or augmentation of labour.
Primary: Postpartum haemorrhage (PPH), heart failure and maternal death. Secondary: Emergency caesarean section, hysterectomy, admission to intensive care unit.
We searched 10 databases, including Medline and Embase, from database inception to 1 October 2018. We included all study designs except cross-sectional studies without a comparator group, case reports, case series, ecological studies, and expert opinion. The searches were conducted by a healthcare librarian and two authors independently screened and reviewed the studies. We used the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approachto ascertain risk of bias and conducted a narrative synthesis.
We identified 3217 journal articles, 223 conference papers, 45 dissertations and 218 registered trials. Ten articles were included for full-text review and only one was found to fulfil the eligibility criteria. This was a retrospective cohort study from India, which showed that pregnant women with moderate and severe anaemia could have an increased risk of PPH if they underwent induction and/or augmentation of labour, but the evidence was weak (graded as 'high risk of bias').
The best approach is to prevent anaemia, but a large number of women in low-to-middle-income countries present with severe anaemia during labour. In such women, appropriate peripartum management could prevent complications and death. Our review showed that at present we do not know if induction and augmentation of labour is safe in pregnant women with iron-deficiency anaemia and further research is required.
CRD42015032421.
进行一项系统评价,以调查缺铁性贫血孕妇引产和/或催产与自然发动的正常分娩相比的安全性。
系统评价。
来自全球所有国家的研究。
分娩时患有缺铁性贫血的孕妇。
任何与引产和/或催产相关的干预措施。
主要指标:产后出血(PPH)、心力衰竭和孕产妇死亡。次要指标:急诊剖宫产、子宫切除术、入住重症监护病房。
我们检索了10个数据库,包括Medline和Embase,检索时间从数据库建立至2018年10月1日。我们纳入了所有研究设计,但不包括无对照组的横断面研究、病例报告、病例系列、生态学研究和专家意见。检索由一名医学图书馆员进行,两名作者独立筛选和审查研究。我们采用推荐分级、评估、制定与评价(GRADE)方法来确定偏倚风险,并进行叙述性综合分析。
我们识别出3217篇期刊文章、223篇会议论文、45篇学位论文和218项注册试验。纳入10篇文章进行全文审查,仅1篇符合纳入标准。这是一项来自印度的回顾性队列研究,该研究表明,中重度贫血孕妇引产和/或催产时产后出血风险可能增加,但证据薄弱(分级为“高偏倚风险”)。
最佳方法是预防贫血,但中低收入国家大量女性在分娩时患有严重贫血。对于这类女性,适当的围产期管理可预防并发症和死亡。我们的评价表明,目前我们尚不清楚缺铁性贫血孕妇引产和催产是否安全,需要进一步研究。
PROSPERO注册号:CRD42015032421。